logo
Select company
Select metric
$ 0Interest Expense
VS
Market
69
Sector
59
Industry
47
History
-
$ 6.2Close
$ 4.52 - $ 10.98 52-Week Range
Ticker Information

Ticker

NVCT

Company Name

NUVECTIS PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NUVECTIS PHARMA INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NVCT - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUVECTIS PHARMA INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 0.
  • Over the past 5 years, NUVECTIS PHARMA INC's average Int. Exp. has been $ 0.
  • The median Int. Exp. for NUVECTIS PHARMA INC during this period was $ 0
  • NUVECTIS PHARMA INC reached its highest Int. Exp. over the past 5 years at $ 0.
  • The lowest Int. Exp. recorded by NUVECTIS PHARMA INC in the same timeframe $ 0

Similar metrics to Int. Exp.:

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

NVCT - Interest Expense, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 0

Maximum

Dec 31, 2020

$ 0

Average

$ 0

Median

Int. Exp. Benchmark Analysis

 The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.79M with a standard deviation of $ 5.55M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.06M
average$ 2.79M
median$ 19.42K
std$ 5.55M